We love the challenge of using social media marketing to increase profits for businesses!!! Local, Nationwide and Worldwide. The internet has endless possibilities. Social networks have changed the way people research and make buying decisions.
IMAGINE BEING ABLE TO TURN EVERY CUSTOMER INTO A POTENTIAL RAVING FAN WHO WILL ADVERTISE FOR YOU
The information we provide highlights the strengths of the company you represent, while creating a positive image of your company. Everyone is mobile these days (iPhones, ipads, laptops in coffee shops, etc. etc...)
Our Main Goal is to Drive potential clients to your website and keep them informed!
Our Main objectives:
• Account creation & installation
• background and Cover design
• Profile picture
• Profile description
• Populate your accounts
• post to your company accounts daily
• post to our over 400k followers daily
✔They say you shouldn’t judge a book by its cover, but the plain truth is first impressions count and people do judge your social media business page by its cover. And many people are put off by rubbish designs, or worse – no cover picture at all?
They will just click off your page immediately and not read what you have to sell or say. Right? I know you would probably do the same thing... We do!
✔Also, you can have the prettiest cover page online but if you don’t have any followers, it’s a worthless cause, because no one is reading what you put out there.
We will Implement a targeted ‘follow’ campaign to increase your followers per month, ensuring they are of the correct demographic for your business.
✔Lastly, we will search your website for content to post and if at any time you wish to provide us with updates like specials, upcoming events, etc., please email us at any time. We love communication!
We will Make 3 tweets from your business account per day at least 6 days a week. These tweets can be pre-approved by you beforehand if you prefer.
We will Make 3 tweets from our business accounts per day at least 6 days a week which will go to our ever growing over 400k followers.
Twitter, with over 200 million active users, has become one of the most popular social media channels and has created many business growth opportunities to businesses. With Twitter, what used to cost thousands of dollars in advertising can now cost very little!
Facebook has over 1 billion active users. Your Page cover to your Timeline is the most prominent part of your Facebook page.
YouTube has over 800 million active users as well as being one of the main social media channels; YouTube is now the second largest search engine.
No logo? We can also design a logo for you!
Ask us to build a package for you with a quote. Thank you!
Make a difference in Someone's Life Today Phillip J Young, COO
Light Media (OTC Markets: LGMH), Inspirational MultiMedia Specialist, markets, produces and distributes inspirational music, video, video games, print media and entertainment in the Urban Media space through its network of radio, Internet, television, print and special events global business platforms and marketing and alliance partners. Light Media is also the 20th publicly-traded multimedia conglomerate (member) of the prestigious RBR-TVBR Stocks Index (see full RBR-TVBR Media Index listing at: http://www.RBR.com
LGMH Key Company Management
Danny Wilson, President & CEO of Light Media has over 25 years of radio, television, media marketing and promotions expertise from 1986 to 2012. Mr. Wilson served as an announcer at a New Orleans, Louisiana, radio station. He expanded his communications knowledge by working as an apprentice at the local public television station. There he took on the role of a camera operator and produced one-hour segments for a weekly show. Mr. Wilson later accepted a position at KTCA, a television station in St. Paul, Minnesota; however, the position for which he had been hired was eliminated. As luck would have it, he was offered a job as Assistant Program Director/Announcer at WRNB Radio in Minneapolis, Minnesota.
Following his stint at WRNB, Mr. Wilson served as an Event Producer with the Contemporary Group, an event-marketing firm based in St. Louis, Missouri. For three years, he traveled with the CBS College Tour to promote CBS network programming to college students at 45 universities across the country. After the third year, Mr. Wilson accepted a position with Entertainment Marketing in Chicago, Illinois, whose major client was Anheuser Busch. Danny’s job was to market and promote the Budweiser Superfest Tour.
As the Budweiser Superfest Road Manager/Representative, Mr. Wilson had the pleasure of interacting with many talented artists, such as Mary J. Blige, Boyz II Men, Pattie LaBelle and Dru Hill, as well as Bones, Thugs and Harmony, New Edition, BlackStreet, Keith Sweat, After 7, Frankie Beverley and Maze, and Montell Jordan, to name a few. Out of this experience with The Contemporary Group and Entertainment Marketing, Mr. Wilson created Dominique's World Productions, Inc., a road management and consulting company that developed and executed tours. His first client as road manager was Def Jam recording artist, LL Cool J.
Mr. Wilson's success with LL Cool J opened the door to work with Montell Jordan. He also managed promotional tours with Def Jam Music Group, the "How to Be a Player" Promotional Tour and the EPMD "Back in Business" Promotional Tour. His relationship with Def Jam afforded Mr. Wilson the opportunities to road manage Jay Z on the Bad Boy Entertainment/"Puff Daddy and the Family Tour.” Another door on the second leg of the tour opened, and Mr. Wilson became the road accountant for Puffy and the Bad Boy Family.
Mr. Wilson served as president and Chief Executive Officer of Dominique's World Productions, Inc., developing and executing marketing programs for major corporations as well as providing consulting services and executing tour agendas for music and entertainment companies. In his capacity of President of Light Media, Mr. Wilson has produced more than 2000 hours of audio and video content, as well as programmed radio and video programs, and guided strategic planning, fundraising and corporate operations from media conglomerate concept idea inception and foundation in September 1997 to today, involved in every aspect and evolution of the company.
LGMH Contact Info Light Media Holdings, Inc.
P.O. Box 1023
Pine Lake, GA 30072
Investor Relations
(No Compensation)
PYCK Global Marketing
Kissimmee, FL
email: pyckstocks@gmail.com
LGMH Recent Developments
Thursday, February 21, 2013 LIGHT MEDIA HOLDINGS, INC. Financials
Tuesday, January 22, 2013 Light Media Acquires LGMH.com
Quote:
Atlanta, Jan. 22, 2013 (GLOBE NEWSWIRE) -- Light Media (OTC Markets: LGMH), Inspirational Media Specialist, announced today that it has acquired top-level (.Com) internet domain: http://www.LGMH.com LGMH is a widely-used and popular internet acronym for the phrase "Love Gives Me Hope" which refers to true personal stories of inspirational individual triumph overcoming adversity (for examples, please visit the LoveGivesMeHope website or Facebook (@LoveGivesMeHope -- which Facebook page has over 180,000 likes for the internet term/acronym known as 'LGMH'/Love Gives Me Hope'). Leveraging viral marketing and .Com top-tier Google search positioning, the goal will be for 'LGMH.com' to be eternally tied to Light Media's corresponding 'LGMH' Stock Ticker Symbol. LGMH.com was previously-owned by an Asia-based consortium since 2003, and the transaction was closed after months of negotiations. Subsequently, the acquisition of LGMH.com now brings Light Media's internet properties' portfolio to a total of 92 high-value internet domain names.
Wednesday, December 5, 2012 "Light Media Adopts Stock Repurchase Program"
Quote:
ATLANTA, Dec. 5, 2012 /PRNewswire/ -- Light Media (OTC Markets: LGMH), Inspirational Media Specialist, announced today that it has adopted a program to repurchase up to 5% of its issued and outstanding shares, or up to 2,250,000 common shares (hereinafter referred to as "LGMH Stock Repurchase Program"). LGMH Stock Repurchase Program permits common shares to be purchased in open market or private transactions, through block trades, and/or pursuant to any stock trading plan.
LGMH Stock Repurchases would be discretionary and at prices the company considers to be attractive and in both the best interests of Light Media and its stockholders, subject to availability of stock, general market conditions, trading prices, alternative uses for capital, etc. LGMH Stock Repurchase Program may be suspended, terminated or modified at anytime for any reason, including but not limited to market conditions, the cost of repurchasing shares, and the availability of alternative investment opportunities. These factors may also affect the timing and amount of share repurchases. LGMH Stock Repurchase Program does not obligate the company to purchase any particular number of shares, and there is no guarantee as to the exact number of shares to be repurchased. Any and all share repurchases which may be made from time to time by Light Media would be noted in reports – beginning with the 4th quarterly period ending on 12/31/2012.
"Nasdaq-listed Salem Communications CEO's March 8, 2012 earlier publicly-trumpeted dividend strategic announcement was intriguing and inspirational. Light Media, as the 2nd only inspirational media asset/platform-centric, publicly-traded media company in the United States, (the other inspirational media conglomerate being Salem Communications), believes that its LGMH Stock Repurchase Program may also serve as an excellent way to increase market awareness of Light Media (core assets, market, opportunities, etc.), while simultaneously positively positioning for the future. Light Media remains steadily and strategically focused as the Inspirational Media Specialist; and there is more news to come," said Danny Wilson, CEO, Light Media.
The following news article excerpts below are shared For Fair Use Exception Discussion and Commentary Purposes Only: In an October 17, 2012 financial commentary by Morningstar Research (Alex Bryan – Seeking Alpha) entitled "Dividends or Share Buybacks? A Taxing Dilemma" Key excerpts from Mr. Bryan's timely and insightful article are as follows:
1. "A firm that continues to increase its dividends will be worth less on an after-tax basis than it would be if it had retained the cash or used it to repurchase shares. Even if some companies do not alter their payout behavior to maximize after-tax value, investors looking for cash distributions may be better served by firms with healthy share-repurchase programs. However, it may be worthwhile to give a stronger weight to share buybacks to take advantage of their superior tax efficiency. Most important, in contrast to a dividend where all shareholders get hit with taxes, in a share-buyback program, only those investors who sell their shares back to the issuer receive a cash distribution and recognize taxes on capital gains. This makes share repurchases a more tax-efficient method to distribute cash even when capital gains and dividend tax rates are the same because investors can defer the tax liability."
2. "Yet, according to Ford Equity Research, companies that have followed through on their share-repurchase commitments have outperformed the market by a wide margin. This may be similar to the observed outperformance of high-dividend-paying stocks. It does this by constraining managers' capacity to engage in value-destructive empire-building. Companies that pursue a disciplined policy of returning capital to shareholders, regardless of the method, may outperform precisely because they undertake fewer marginal investments."
Thursday, November 8, 2012 Light Media Enters Into Agreement To Divest Power 105.5/The King
Thursday, October 25, 2012 Light Media Reports Q3 2012 Results
Quote:
ATLANTA, Oct. 25, 2012 /PRNewswire/ -- Light Media (OTC Markets: LGMH), Inspirational Media Specialist, announced today its results for the quarterly-period ending September 30, 2012 as compared to the quarterly-period ending June 30, 2012, as follows:
* Revenues were $17,837 as of September 30, 2012 versus $23,916 for the quarterly-period ending June 30, 2012.
* Cost of sales were $2,987 as of September 30, 2012 versus $7,481 for the quarterly-period ending June 30, 2012.
* Selling, general and administrative expenses were $14,265 as of September 30, 2012 versus $18,229 for the quarterly-period ending June 30, 2012.
Wednesday, August 15, 2012 Light Media Reports Q2 2012 Results
Quote:
* Revenues were $23,916 as of June 30, 2012 versus $21,405 for the quarterly-period ending June 30, 2011 – an increase of 10.5%.
* Cost of sales were $7,481 as of June 30, 2012 versus $5,938 for the quarterly-period ending June 30, 2011.
* Selling, general and administrative expenses were $18,229 as of June 30, 2012 versus $45,902 for the quarterly-period ending June 30, 2011.
Thursday, July 12, 2012 Dice Gamble: Bet On Love In-Stores Now
Thursday, May 31, 2012 BJ Hardy: With All My Heart in Stores Now
Wednesday, May 16, 2012 Light Media Q1 2012 Revenues Rise 47.59%
Quote:
Revenues were $20,197 as of March 31, 2012 versus $10,585 for the quarter-ended March 31, 2011. Cost of sales were $5,069 as of March 31, 2012 versus $4,131 for the quarter-ended March 31, 2011. Selling, general and administrative expenses were $23,442 as of March 31, 2012 versus $13,261 for the quarter-ended March 31, 2011.
Three (3) Key LGMH Q1 2012 Media Platform Synergy Accomplishments:
Attained Apple IOS Developer Certification, enabling development and deployment of iPhone/iPad Apps.
3 New Product Releases.
24 New Advertising partners.
Monday, May 14, 2012 Light Media Issues Corporate Credo
Friday, May 11, 2012 Light Media Releases PrayerMail App in iTunes
Monday, May 7, 2012 Light Media Divests Ownership Stake In ChristianCapitalFund.com
Thursday, May 3, 2012 Light Media Supports National Day of Prayer: May 3, 2012
Quote:
Cautionary Note Regarding Forward-Looking Statements: This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Light Media (OTC: "LGMH") and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.
Industry: Media & Entertainment Inspirational Radio, Music, Video, Video-Games and Entertainment.
Digital: Light Media Network Websites, Domains and/or Digital Real Estate Properties now total: 92
Apple Developer License. Light Media has been formally approved as an authorized Apple Inc. Developer. This particular update is a follow-up on the October 21, 2011 press release, where Light Media announced its intention to develop its own mobile applications. The first App developed and tested by Light Media's engineering team is:
PrayerMail ,PrayerMail will be available on the Apple Store worldwide within the next 30-days. On February 17, 2012, Apple announced 24.7 Billion downloads of Apps in its Apple Apps Store; and Apple and Android devices now saturate 80% of the US smartphone market. Forrester Research estimates 1 billion smartphones and an Apps market value of $55 Billion by 2016. Light Media has intensively and strategically acquired and aggregated a strong stable of 'Prayer' assets such as: PrayerMail.com, PrayerSpace.com and PrayerWall.com, over the past 36 months, in order to gain a critical inroad into an important and growing vertical segment of the faith-based space. Prayer is ubiquitous and used by billions of persons 24/7 and PrayerMail and PrayerWall are common term, used by ministries and individuals worldwide, and Light Media's PrayerMail App will be the first of many innovations to come. For more information, please visit:http://www.PrayerMail.com
HotChristianStocks.com Light Media formed a strategic alliance with Pyck Global Marketing, whereby HotChristianStocks.com was strategically merged to created StockPycks.com, a marketing platform focused on bringing greater visibility to up and coming micro-cap, publicly-traded stocks. Pyck Global Marketing has assumed all day-to-day operational control of the merged digital media property. For more information, please visit: http://www.StockPycks.com
AmenGospel.com: Light Media successfully launched AmenGospel.com, growing from 17 to 38 inspirational artists within 30-days, adding to the 1700 independent inspirational artists who call www.GospelEngine.com home. For more information, please visit: http://www.AmenGospel.com
Local Marketing Alliance. Light Media's strategic alliance with The Metro Gazette has created substantial momentum within and throughout Metro Albany. Guest speakers ranging from the President of Albany State University to US Congress Representatives and local ministry and community officials have been on the airwaves via the weekly show that the Publisher of The Metro Gazette airs on Power 105.5/The King (Wednesdays @ 3PM). This positioning has increased local community support, as well as provided advertisers with a win-win and highly-compelling, value-added combo print and radio media marketing package.
Corporate: Light Media continues to build its Strategic Advisory Council, as well as actively negotiate relationships with value-added strategic alliance partners.
(.Com) internet domain:http://www.LGMH.com LGMH is a widely-used and popular internet acronym for the phrase "Love Gives Me Hope" which refers to true personal stories of inspirational individual triumph overcoming adversity (for examples, please visit the LoveGivesMeHope website or Facebook (@LoveGivesMeHope -- which Facebook page has over 180,000 likes for the internet term/acronym known as 'LGMH'/Love Gives Me Hope'). Leveraging viral marketing and .Com top-tier Google search positioning, the goal will be for 'LGMH.com' to be eternally tied to Light Media's corresponding 'LGMH' Stock Ticker Symbol.
OTC Pink™ Current Information
Companies that follow the International Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to OTC Markets Group Guidelines for Providing Adequate Current Information (pdf) are designated as OTC Pink Current Information.
Light Media Holdings, Inc. follows under these guidelines on the OTC Pink current information market tier.
Share Structure
Shares Outstanding 42,762,500 a/o Feb 12, 2013
Float 11,562,495 a/o Feb 12, 2013
Authorized Shares 100,000,000 a/o Feb 12, 2013
Par Value 0.0001
Shareholders
Shareholders of Record: 88 a/o Feb 12, 2013 Transfer Agent(s)
Registrar and Transfer Co.
10 Commerce Dr.
Cranford, 07016-1010
800-456-0596 http://www.rtco.com
Financial Reporting/Disclosure
Reporting Status: Alternative Reporting Standard
CIK: 0001464192
Fiscal Year End: 12/31
Profile Data
SIC - Industry Classification: 3652 - Prerecorded records and tapes
Business Status Development Stage Company: Development Stage Company a/o Oct 14, 2010
Incorporated In: DE, USA
Year of Inc: 2006
Before You Invest - Investigate! Always do your own due diligence
A critical part of the due diligence: Please be aware, that upon completion of in-depth due diligence there is still a risk factor in all forms of investing.
Please note not all company websites are updated on a regular basis so you should use additional content sources to ensure accuracy.
Resources used in this post: otcmarket.com, www.bloomberg.com, www.finance.yahoo.com, LGMH website
VSTA Business Description
VistaGen Therapeutics Inc. is biotechnology company harnessing the revolutionary power of human pluripotent stem cell technology for drug rescue and cell therapy.
VistaGen's drug rescue activities involve the combination of its human pluripotent stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of small molecule drug candidates that pharmaceutical companies have discontinued during preclinical development ("put on the shelf") due to heart or liver toxicity, despite promising efficacy data. VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube(TM), is based on directed differentiation (development) of human pluripotent stem cells into multiple types of mature cells. With heart cells produced from stem cells, VistaGen has developed CardioSafe 3D(TM), a three-dimensional biological assay (screening) system the company believes is capable of predicting the human cardiac effects, both toxic and non-toxic, of new drug candidates, long before they are tested in humans. VistaGen's immediate goal is to leverage CardioSafe 3D(TM) to generate and monetize a pipeline of small molecule drug candidates through drug rescue collaborations. VistaGen intends to expand its drug rescue capabilities by introducing LiverSafe 3D(TM), a human liver cell-based toxicity and metabolism bioassay system. In collaboration with Dr. Gordon Keller, recently named a "Top 25 Transformational Canadian" for his pioneering stem cell research and technology, VistaGen is also advancing pilot preclinical development of large market cell therapy programs, including cartilage, heart and liver repair
WATCH AWESOME AT THE BOTTOM OF THIS DD!
VSTA Pipeline and Technologies
Human Clinical Trials in a Test Tube™
$VSTA CardioSafe 3D™ is a novel bioassay system that uses mature human heart cells derived from pluripotent stem cells to screen for heart toxicity in connection with our drug rescue activities. We believe CardioSafe 3D™ is stable, reproducible and capable of generating data to allow more accurate prediction of the in vivo cardiac effects, both toxic and nontoxic, of promising new drug candidates long before they are tested in humans.
$VSTA LiverSafe 3D™
In collaboration with Dr. Gordon Keller, one of the world’s leading stem cell researchers, we are developing engineered cell lines and enhancing protocols to control the differentiation of pluripotent stem cells into normal, mature, human liver cells for use in a novel liver cell-based bioassay system for predicting liver toxicity and metabolism issues in connection with our drug rescue activities. We refer to this novel human liver cell-based bioassay system as LiverSafe 3D™. We plan to complete development of LiverSafe 3D in early-2013.
$VSTA AV-101, also known as “L-4-chlorokynurenine” and “4-Cl-KYN”, is a novel prodrug candidate that we are developing for the treatment of neuropathic pain. We are also considering AV-101 Phase 2 development opportunities relating to epilepsy, Parkinson’s disease and depression.
AV-101 is a novel, orally available prodrug that is converted in the brain into an active metabolite, 7-chlorokynurenic acid (7-Cl-KYNA), which is an antagonist of the N-methyl-D-aspartate (NMDA) receptors. 7-Cl-KYNA is a synthetic analogue of kynurenic acid, a naturally occurring CNS regulatory compound, and is one of the most potent and selective blockers of the regulatory GlyB-site of the NMDA receptor.
In pre-clinical studies, AV-101 has demonstrated very good levels of oral bioavailability, rapid and efficient transport across the blood-brain barrier and preferential conversion into 7-CKYNA at the site of seizures and potential neural damage in the brain and spinal cord.
AV-101 is completing Phase 1 development in the U.S. under an active Investigational New Drug (IND) application on file at the U.S. FDA that defines the initial clinical development for neuropathic pain.
We believe the safety studies completed in our AV-101 Phase 1 clinical program may also enable Phase 2 development of AV-101 for epilepsy, Parkinson’s disease and depression.
Technology:http://www.vistagen.com/technology/default.aspx
Our Human Clinical Trials in a Test Tube™ platform is based upon a combination of proprietary and exclusively licensed stem cell technologies, including technologies developed over the last 20 years by our co-founders, renowned Canadian stem cell scientist, Dr. Gordon Keller, and Dr. Ralph Snodgrass, our President and Chief Scientific Officer.
VSTA Key Company Management
Shawn K. Singh CEO
H. Ralph Snodgrass President, CSO
Jerrold D. Dotson CFO
A. Franklin Rice VP, Corp. Dev.
Shawn Singh, J.D. Chief Executive Officer, Director
Mr. Singh has over 20 years of experience working with public and private biotechnology and pharmaceutical companies,serving in numerous senior management roles. He served as Managing Principal of Cato BioVentures, a biopharmaceutical venture capital firm, as Chief Business Officer of Cato Research Ltd., a global contract research and development organization (CRO), as President of Echo Therapeutics (Nasdaq: ECTE), a medical device company targeting diabetes management, and as Chief Business Officer of SciClone Pharmaceuticals (Nasdaq: SCLN), a revenue-producing specialty pharmaceutical company focused on cancer and infectious disease. Mr. Singh began his career as a corporate finance attorney in the Silicon Valley offices of Morrison & Foerster LLP. Mr. Singh is a member of the State Bar of California.
Quote:
SOUTH SAN FRANCISCO, CA--(Marketwired - Apr 10, 2013) - VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism assays, today announces the signing of a strategic financing agreement with the European subsidiary of Bergamo Acquisition Corp. (OTC: BGMO), a global diversified investment holding company.
Under the terms of the agreement, Bergamo's European subsidiary will invest $36 million in VistaGen in consideration for 72 million shares of restricted VistaGen Common Stock at a price of $0.50 per share. The Company's self-placed strategic financing does not include warrants or any investment banking fees. The transaction is scheduled to close on or before April 30, 2013. At closing, the shares issued in connection with the strategic financing will represent a majority of the issued and outstanding shares of VistaGen's Common Stock.
VistaGen plans to use proceeds of the financing to accelerate and expand its stem cell technology-based drug rescue programs. Using its innovative CardioSafe™ 3D and LiverSafe™ 3D bioassay systems and modern medicinal chemistry, the Company is focused on generating new, safer, proprietary variants (Drug Rescue Variants) of once-promising small molecule drug candidates discontinued in development by large pharmaceutical companies due to heart or liver safety issues. In collaboration with co-founder and renowned stem cell research scientist, Dr. Gordon Keller, as well as long-term strategic partner, the University Health Network in Toronto, and several other leading academic and corporate collaborators, VistaGen also plans to advance new pilot nonclinical regenerative cell therapy programs and certain other emerging commercial opportunities related to its Human Clinical Trials in a Test Tube™ platform.
"Since our inception nearly 15 years ago, we have carefully deployed more than $53 million, including over $15 million from grant awards and collaboration revenue, to successfully develop innovative stem cell technology and bioassay systems capable of bringing clinically relevant human heart and liver biology to the front end of the drug development process," stated Shawn K. Singh, VistaGen's Chief Executive Officer. "Upon the closing of this transformative financing, our strong long-term financial position will enhance substantially our ability to drive our core programs to valuable commercial outcomes."
VISTAGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
EDGAR Online (Wed, Apr 10) http://biz.yahoo.com/e/130410/vsta8-k.html VistaGen Announces $36 Million Strategic Financing Agreement
Marketwired (Wed, Apr 10)
Wednesday, March 13, 2013 VISTAGEN THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an O
EDGAR Online (Wed, Mar 13) http://biz.yahoo.com/e/130313/vsta8-k.html
Wednesday, March 6, 2013 VISTAGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S
EDGAR Online (Wed, Mar 6) http://biz.yahoo.com/e/130306/vsta8-k.html
Thursday, February 28, 2013 VISTAGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fina
EDGAR Online (Thu, Feb 28) http://biz.yahoo.com/e/130228/vsta8-k.html
Quote:
During the first three quarters of our fiscal year ending March 31, 2013, we have continued to expand the capabilities of CardioSafe 3D and develop LiverSafe 3D. Additionally, we have continued to advance our review of prospective drug rescue candidates and have completed Phase 1 clinical development of AV-101. Our efforts during the third quarter were primarily directed to finalizing and analyzing the AV-101 Phase 1b clinical trial results and preparing final clinical study reports required under the terms of our NIH grant awards. Our executive management has been significantly focused on providing sufficient operating capital to advance our research and development objectives while meeting our continuing operational needs. To that end, we have entered into strategic debt restructuring agreements with certain long-term service providers and research and development collaborators to modify the payment requirements of our liabilities to them by significantly reducing the monthly cash payment requirements related to them, or in certain cases, to entirely restructure the liability so that it is now payable only in shares of our common stock. During the quarter ended September 30, 2012, we entered into such a strategic debt restructuring agreement with Morrison & Foerster ("M&F"), our long term outside legal counsel for intellectual property matters and certain other general corporate and finance matters. Pursuant to the M&F strategic debt restructuring agreement, we converted approximately $1.4 million of our then-existing promissory note debt to M&F into a new unsecured promissory note payable only in shares of our common stock in connection with M&F's future exercise of a warrant to purchase approximately 1.4 million shares of our common stock at $1.00 per share, provided, however, that M&F has the option to require us to repay the note in cash upon a change of control or event of default, as both are defined in the agreement. In October 2012, we entered into similar strategic debt restructuring agreements with Cato Research Ltd. ("CRL"), our CRO collaborator for preclinical and Phase 1 clinical development of AV-101, and University Health Network ("UHN"), our long-term stem cell research and development collaborator in Canada, in which we converted approximately $1.0 million of existing accounts payable debt owed to CRL and approximately $0.55 million of existing accounts payable debt owed to UHN into new notes payable only in shares of our common stock in connection with future warrant exercises by CRL and UHN to purchase approximately 1.0 million and 0.55 million shares of our common stock, respectively, at $1.00 per share. Additionally, we have reduced the current monthly unsecured promissory note payment requirements with respect to existing debt of $1.0 million owed to M&F and $0.3 million owed to Cato Holding Company. Further, we have entered into an agreement with our largest institutional investor, Platinum Long Term Growth VII, LLC ("Platinum"), pursuant to which we expect to receive an aggregate of $3.25 million in cash proceeds, $2.25 million of which we have already received, from the issuance of senior secured convertible promissory notes and related warrants to purchase 3.25 million shares of our common stock. Subject to certain adjustments, these notes are convertible into shares of our common stock at a conversion price of $0.50 per share and the warrants are exercisable at an exercise price of $1.50 per share. Additionally, we modified Platinum's exchange rights with respect to the shares of our Series A preferred stock that it holds. These transactions are described in greater detail in Note 7, Convertible Promissory Notes and Other Notes Payable and Note 9, Capital Stock, in the Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q. The accounting for these transactions has resulted in the recognition of non-cash losses due to certain of the modifications (loss on early extinguishment of debt) and non-cash interest expense in the financial statements for the quarter and fiscal year-to-date. These transactions, which will potentially require or permit the issuance of shares of our common stock at various points in the future, may be substantially dilutive to our existing stockholders.
OTCQB®
The OTCQB market tier helps investors easily identify companies that are current in their reporting obligations with the SEC or report to a U.S. banking or insurance regulator. OTCQB securities are quoted on OTC Markets Group's quotation and trading system and some may also be quoted on FINRA's BB
VSTA follows under these guidelines on the OTCQB market tier.
VSTA Share Structure
Shares Outstanding 20,421,787 a/o Feb 21, 2013
Float 1,101,693 a/o Feb 21, 2013
Authorized Shares 200,000,000 a/o Feb 21, 2013
Par Value 0.001
per otcmarkets.com 4/13/13
Transfer Agent(s)
Registrar and Transfer Co.
10 Commerce Drive
Cranford, NJ, 07016-1010
908-497-2300 http://www.rtco.com
Company Notes
Formerly=Excaliber Enterprises Ltd. until 6-2011 Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2005 Security Notes
Capital Change=shs increased by 2 for 1 split, payable upon surrender.. Pay date=06/10/2011
VSTA bio video -Cardiac OrganDots(TM) Produced for Drug Rescue
Before You Invest - Investigate! Always do your own due diligence
A critical part of the due diligence: Please be aware, that upon completion of in-depth due diligence there is still a risk factor in all forms of investing.
Please note not all company websites are updated on a regular basis so you should use additional content sources to ensure accuracy.
Resources used in this post: otcmarket.com, www.bloomberg.com, www.finance.yahoo.com, VSTA website
Twitter, with over 200 million active users, has become one of the most popular social media channels and has created many business growth opportunities to businesses. With Twitter, what used to cost thousands of dollars in advertising can now cost very little!
Facebook has over 1 billion active users. Your Page cover to your Timeline is the most prominent part of your Facebook page.
YouTube has over 800 million active users as well as being one of the main social media channels; YouTube is now the second largest search engine.
AT THE BOTTOM OF THIS DD! 
